MIRA INFORM REPORT

 

 

Report Date :

28.08.2014

 

 

 

 

Tel. No.:

91-130-2484108

Fax No.:

91-130-2484109

 

 

IDENTIFICATION DETAILS

 

Name :

ANCALIMA LIFESCIENCES LIMITED

 

 

Formerly Known As:

UNI SULE LABORATORIES PRIVATE LIMITED (w.e.f. 08.07.2006)

PFISCAR INDIA LIMITED

 

 

Registered Office :

2071, Old Anaj Mandi, Narela, Delhi - 110040

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

02.05.1988

 

 

Com. Reg. No.:

55-31451

 

 

Capital Investment / Paid-up Capital :

Rs. 4.935 Millions

 

 

CIN No.:

[Company Identification No.]

U52110DL1988PLC031451

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELP06518B

 

 

PAN No.:

[Permanent Account No.]

AACCP5005B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical and Veterinary Formulation.

 

 

No. of Employees :

48 [In Office : 13; In Factory : 25]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 32000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having moderate track. Profitability of the company appears to be low. However trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Manish Pandey

Designation :

Account

Contact No.:

91-130-2484108

Date :

16.08.2014

 

 

LOCATIONS

 

Registered Office :

2071, Old Anaj Mandi, Narela, Delhi – 110040, India

Tel. No.:

91-130-2484108

Mobile :

91-9896008786 / 8059208786 (Mr. Rajeev Garg)

Fax No.:

91-130-2101076

E-Mail :

arunahuja_7@rediffmail.com

admin@ancalima.com

sales@ancalima.com

exports@ancalima.com

rg@ancalima.com

Website :

http://www.ancalima.com

Area :

Rented

 

 

Factory :

50th Km Stone, National Highway No.1, Murthal, Sonepat – 131 039, Haryana, India

Tel. No.:

91-130-2484108

Mobile No.:

91-9896084700 [Mr. Rajeev Garg]

Fax No.:

91-130-2484109

Area :

Owned

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Mr. Rajeev Garg

Designation :

Director

Address :

935, Sector – 15, Sonepat – 133 101, Haryana, India

Date of Birth/Age :

01.11.1972

Date of Appointment :

15.02.1996

DIN No.:

00159925

Other Directorship :    

                

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U52110DL1988PLC031451

ANCALIMA LIFESCIENCES LIMITED

Director

15-02-96

15-02-96

-

Active

NO

2

U24112UP1948PTC001882

THE NEW INTERNATIONAL CHEMICALS PRIVATE LIMITED

Director

14-08-97

14-08-97

-

Active

NO

3

U24233DL2005PLC140455

UTTARANCHAL BIOTECH LIMITED

Director

28-02-07

28-02-07

16-10-08

Active

NO

 

 

Name :

Ms. Garg Sakshi

Designation :

Director

Address :

935, Sector – 14, Sonepat , Haryana, India

Date of Birth/Age :

14.12.1974

Date of Appointment :

02.05.1988

DIN No. :

00159945

Other Directorship :    

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U52110DL1988PLC031451

ANCALIMA LIFESCIENCES LIMITED

Director

01-02-05

01-02-05

-

Active

NO

2

U24112UP1948PTC001882

THE NEW INTERNATIONAL CHEMICALS PRIVATE LIMITED

Director

28-09-12

28-09-12

-

Active

NO

 

 

Name :

Ms. Sita Ram Garg

Designation :

Director

Address :

935, Sector – 14, Sonepat– 131001, Haryana, India

Date of Birth/Age :

20.06.1943

Date of Appointment :

02.11.2009

DIN No.:

00455602

Other Directorship :    

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

 

 

 

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24112UP1948PTC001882

THE NEW INTERNATIONAL CHEMICALS PRIVATE LIMITED

Director

01-06-85

01-06-85

-

Active

NO

2

U24233DL2005PLC140455

UTTARANCHAL BIOTECH LIMITED

Director

05-01-09

07-09-05

24-10-09

Active

NO

3

U52110DL1988PLC031451

ANCALIMA LIFESCIENCES LIMITED

Director

02-11-09

02-11-09

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Manish Pandey

Designation :

Account

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2013

 

Names of Shareholders

No. of Shares

Sita Ram Garg

11

.Nirmla Garg

1

Raghbir Chand Garg

501

Sukhdev Garg

10

Gore Lal

01

Shanti Devi

01

Ashok Kumar

01

Bhagwati Devi

01

Atma Ram

01

Nirmal Goel

01

Minakshi Garg

01

Natasha Garg

01

Kaushlya Devi

01

Rajeev Garg

33277

The New India International Chemicals Private Limited

13300

Surat Singh Kuhar

01

Sakshi Garg

2225

Viran Jain & Sons (Huf)

01

Rajeev Garg (Huf)

10

Veena Jain

5

TOTAL

49351

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical and Veterinary Formulation.

 

 

Product :

·         Cosmetic Formulation

o        Hair Shampoo 100 mL

o        Neem & Honey Face Wash 70ml

o        Famine Wash

o        Moisturizing Lotion

o        Sun Screen Gel

·         Dry Powder Injections-Human

o        Meropenem Injection 250mg

o        Imipenem & Cilastatin Injection 1 g.

o        Piperacillin & Tazobactam Injection 2.250g.

o        Vancomycin Injection 500mg

o        Ceftazidime & Tazobactam Injection 1.125 g.

o        Cefuroxime Injection 750mg

·         Liquid Injections - Human

o        Clindamycin Injection 2ml

o        Ondansetron Injection 2 ml.

o        Iron Sucrose Injection 2.5ml.

o        Nandrolone Decanoate 25mg.

·         Veterinary Formulations

o        Meloxicam-20 30ml & 50ml & 100ml

o        Nandrolone Decanoate 5 ml

o        Ivermectin 2ml & 50ml

o        Cyanocobalamin & Cholecalciferol Injection 45 ml

·         External Applications

o        Clindamycin 1 % + Adapalene 0.1% Gel

o        Clindamycin 1% + Isotretinoin 0.5 % Gel

o        Ketoconazole + ZPTO Hair Lotion

o        Clindamycin 1% Gel

·         Formulations for Export Only

o        Paraldehyde Injection

o        Dex-Ketoprofen 100mg/2ml Injection

o        Ketoprofen Inj. 100mg/2ml

o        Phytomenadione Injection 10mg/ml

 

 

Exports :

 

Countries :

·         Afghanistan

·         Nigeria

 

 

Terms :

 

Selling :

Cash and Credit (60 Days)

 

 

Purchasing :

Cash and Credit

 

 

 

GENERAL INFORMATION

 

Customers :

·         Wholesalers

·         Pharma AG Trading

·         Santo Domingo

·         Dominican Republic

·         Cera  Medical Limited

 

 

No. of Employees :

48 [In Office : 13; In Factory : 25]

 

 

Bankers :

  • HDFC Bank, Delhi
  • HDFC Bank, Sonepat
  • ICICI Bank
  • Canara Bank, Atlas Road, Sonipat – 131 001, Haryana, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

Long Term Borrowings

 

 

Term Loans:

 

 

From Banks

1.227

1.645

Short Term Borrowings

 

 

Working Capital Loans

 

 

From Bank

12.428

11.832

Total

13.655

13.477

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Ahuja Arora and Associates

Chartered Accountants

Address :

N-146, Greter Kailash Part-1, , New Delhi- 110 048, India

Tel. No.:

91-29243799 / 29243800

Mobile No.:

919810069885

E-Mail :

arunahujs.7@gmail.com

PAN No. :

AAGFA7637P

 

 

Associates/Subsidiaries :

The New International Chemicals Private Limited

 

 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.100/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

49351

Equity Shares

Rs.100/- each

Rs.4.935 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

4.935

4.935

(b) Reserves & Surplus

 

3.166

2.322

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

8.101

7.257

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

14.177

14.124

(b) Deferred tax liabilities (Net)

 

0.378

0.086

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.957

0.865

Total Non-current Liabilities (3)

 

15.512

15.075

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

12.428

11.832

(b) Trade payables

 

23.688

27.069

(c) Other current liabilities

 

5.404

3.598

(d) Short-term provisions

 

2.516

2.108

Total Current Liabilities (4)

 

44.036

44.607

 

 

 

 

TOTAL

 

67.649

66.939

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

15.699

15.242

(ii) Intangible Assets

 

0.079

0.099

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.150

0.150

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.143

0.140

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

16.071

15.631

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

16.177

20.939

(c) Trade receivables

 

28.982

26.228

(d) Cash and cash equivalents

 

1.029

0.601

(e) Short-term loans and advances

 

3.751

2.171

(f) Other current assets

 

1.639

1.369

Total Current Assets

 

51.578

51.308

 

 

 

 

TOTAL

 

67.649

66.939

 

 

SOURCES OF FUNDS

 

 

 

31.03.2011

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

4.934

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

1.391

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

6.325

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

12.421

2] Unsecured Loans

 

 

13.530

TOTAL BORROWING

 

 

25.951

DEFERRED TAX LIABILITIES

 

 

0.235

 

 

 

 

TOTAL

 

 

32.511

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

14.531

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.150

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

20.417

 

Sundry Debtors

 

 

18.632

 

Cash & Bank Balances

 

 

0.266

 

Other Current Assets

 

 

1.775

 

Loans & Advances

 

 

2.338

Total Current Assets

 

 

43.428

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

 

Other Current Liabilities

 

 

23.443

 

Provisions

 

 

2.155

Total Current Liabilities

 

 

25.598

Net Current Assets

 

 

17.830

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

32.511

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

91.492

89.701

79.195

 

 

Other Income

4.834

3.916

2.094

 

 

TOTAL                                     (A)

96.326

93.617

81.289

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

59.766

64.125

62.215

 

 

Purchases of Stock-in-Trade

2.787

1.329

0.000

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

1.338

(0.682)

0.000

 

 

Employees benefits expense

6.499

6.229

4.925

 

 

Managerial remuneration

1.650

1.260

0.900

 

 

Payment to auditors

0.101

0.084

0.083

 

 

Interest

0.000

0.000

2.366

 

 

Insurance Expenses

0.223

0.286

0.166

 

 

Power and Fuel

2.541

2.201

1.773

 

 

Other expenses

14.261

12.165

6.051

 

 

TOTAL                                     (B)

89.166

86.997

78.479

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

7.160

6.620

2.810

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

3.092

2.944

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

4.068

3.676

2.810

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

2.283

2.189

1.766

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

1.785

1.487

1.044

 

 

 

 

 

Less

TAX                                                                  (H)

0.941

0.556

0.166

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

0.844

0.931

0.878

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

NA

NA

1.391

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

TOTAL EARNINGS

0.471

0.470

40.082

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

NA

0.138

 

TOTAL IMPORTS

NA

NA

0.138

 

 

 

 

 

 

Earnings Per Share (Rs.)

17.11

18.87

17.81

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

0.88

0.99

1.08

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.95

1.66

1.32

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.64

2.23

1.80

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.22

0.20

0.16

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

3.28

3.58

4.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.17

1.15

0.58

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

4.935

4.935

Reserves & Surplus

2.322

3.166

Net worth

7.257

8.101

 

 

 

long-term borrowings

14.124

14.177

Short term borrowings

11.832

12.428

Total borrowings

25.956

26.605

Debt/Equity ratio

3.577

3.284

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

79.195

89.701

91.492

 

 

13.266

1.997

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

79.195

89.701

91.492

Profit

0.878

0.931

0.844

 

1.11%

1.04%

0.92%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

Note: Registered office of the company has been shifted from A-337,Lgf-2 Basement, Shivalik, Delhi, Central Delhi-110017, Delhi, India to the present address w.e.f. 16.11. 2009

 

LATIGATION DETAILS

 

 

                                                     IN THE HIGH COURT OF DELHI AT NEW DELHI

  CS(OS) 1420/2013

 

  DR.REDDY S LABORATORIES LTD ..... Plaintiff

  
  Through: Ms. Sabia Veqar, Adv.

  
   versus
  
    
  ANCALIMA LIFESCIENCES LIMITED AND ORS ..... Defendants

 
 Through: Mr. Siddhanth Bambha, Adv.

  
  CORAM:
  
  SH. KOVAI VENUGOPAL (DHJS), JOINT REGISTRAR (JUDICIAL)

  
   O R D E R

  
   25.07.2014
   
 Today the case is coming up for carrying out admission/denial of the additional documents.

 
Ld. counsel for defendant submits that the additional documents filed by the plaintiff are some promotional    material and invoices which do not pertain to the defendant, therefore, there is no need of carrying   out admission/denial. Admission/denial of the documents stage is taken as complete. Put up before the Hon'ble Court for further directions on date fixed i.e. 29.08.2014.

 

UNSECURED LOAN

 (Rs. In Millions)

Particulars

As on

31.03.2013

As on

31.03.2012

Long Term Borrowings

 

 

Loans and advances from related parties

12.950

12.479

Total

12.950

12.479

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10040053

13/01/2007

1,365,000.00

CANARA BANK

ATLAS ROAD, SONIPAT, HARYANA - 131001, INDIA

A11207883

2

90054987

13/03/2014 *

17,500,000.00

CANARA BANK

CANARA BANK, SONEPAT, HARYANA - 131001, INDIA

C02354496

3

90052716

23/07/2003 *

2,500,000.00

CANARA BANK

SONIPAT, SONIPAT, HARYANA, INDIA

-

 

* Date of charge modification

 

FIXED ASSETS

 

  • Air conditioner
  • Building
  • Building under construction
  • Vehicle
  • CCD Camera
  • Computer
  • Dies and Tools
  • Electrical Equipment
  • EPABX
  • Fire Extinguisher
  • Furniture and Fixture
  • Generator
  • Lab Equipment
  • Land
  • Mobile Phone
  • Plant and Machinery
  • Printer and Scanner
  • Refrigerator
  • Scooter
  • Software
  • Telephone Equipment
  • Vacume Cleaner
  • Weight Machine
  • Water Cooler

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.46

UK Pound

1

Rs. 100.14

Euro

1

Rs. 79.65

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

ASH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.